{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T22:17:52Z","timestamp":1788214672532,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"36","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2025JJ50549"],"award-info":[{"award-number":["2025JJ50549"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,9,22]]},"DOI":"10.1038\/s41388-026-03910-w","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T13:36:23Z","timestamp":1785245783000},"page":"3782-3796","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transcription factor EN1 governs a lipogenic USP18-ACLY axis to drive bladder cancer malignancy"],"prefix":"10.1038","volume":"45","author":[{"given":"Ying","family":"Zhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuqi","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangya","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1458-7215","authenticated-orcid":false,"given":"Zhuo","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"3910_CR1","doi-asserted-by":"publisher","first-page":"e076743","DOI":"10.1136\/bmj-2023-076743","volume":"384","author":"A Lopez-Beltran","year":"2024","unstructured":"Lopez-Beltran A, Cookson MS, Guercio BJ, Cheng L. Advances in diagnosis and treatment of bladder cancer. BMJ. 2024;384:e076743.","journal-title":"BMJ"},{"key":"3910_CR2","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/S0140-6736(22)01188-6","volume":"400","author":"E Comperat","year":"2022","unstructured":"Comperat E, Amin MB, Cathomas R, Choudhury A, De Santis M, Kamat A, et al. Current best practice for bladder cancer: a narrative review of diagnostics and treatments. Lancet. 2022;400:1712\u201321.","journal-title":"Lancet"},{"key":"3910_CR3","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis AT, Lec PM, Chamie K, Mshs MD. Bladder cancer: a review. JAMA. 2020;324:1980\u201391.","journal-title":"JAMA"},{"key":"3910_CR4","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"3910_CR5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","volume":"70","author":"PA Humphrey","year":"2016","unstructured":"Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE. The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: prostate and bladder tumours. Eur Urol. 2016;70:106\u201319.","journal-title":"Eur Urol"},{"key":"3910_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.eururo.2023.08.016","volume":"85","author":"J Alfred Witjes","year":"2024","unstructured":"Alfred Witjes J, Max Bruins H, Carrion A, Cathomas R, Comperat E, Efstathiou JA, et al. European Association of Urology Guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2023 guidelines. Eur Urol. 2024;85:17\u201331.","journal-title":"Eur Urol"},{"key":"3910_CR7","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","volume":"388","author":"AM Kamat","year":"2016","unstructured":"Kamat AM, Hahn NM, Efstathiou JA, Lerner SP, Malmstrom PU, Choi W, et al. Bladder cancer. Lancet. 2016;388:2796\u2013810.","journal-title":"Lancet"},{"key":"3910_CR8","doi-asserted-by":"publisher","first-page":"322","DOI":"10.21037\/tau.2017.03.59","volume":"6","author":"PJ Vlachostergios","year":"2017","unstructured":"Vlachostergios PJ, Jakubowski C, Tagawa ST. Trimodality therapy in variant urothelial carcinoma: choose wisely. Transl Androl Urol. 2017;6:322\u20135.","journal-title":"Transl Androl Urol"},{"key":"3910_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","volume":"79","author":"JA Witjes","year":"2021","unstructured":"Witjes JA, Bruins HM, Cathomas R, Comperat EM, Cowan NC, Gakis G, et al. European Association of Urology Guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines. Eur Urol. 2021;79:82\u2013104.","journal-title":"Eur Urol"},{"key":"3910_CR10","doi-asserted-by":"publisher","first-page":"11805","DOI":"10.2147\/OTT.S231489","volume":"12","author":"Z Cai","year":"2019","unstructured":"Cai Z, Zhang F, Chen W, Zhang J, Li H. miRNAs: a promising target in the chemoresistance of bladder cancer. Onco Targets Ther. 2019;12:11805\u201316.","journal-title":"Onco Targets Ther"},{"key":"3910_CR11","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029\u201333.","journal-title":"Science"},{"key":"3910_CR12","doi-asserted-by":"crossref","unstructured":"Bian X, Liu R, Meng Y, Xing D, Xu D, Lu Z. Lipid metabolism and cancer. J Exp Med. 2021;218:e20201606.","DOI":"10.1084\/jem.20201606"},{"key":"3910_CR13","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ccr.2005.09.008","volume":"8","author":"G Hatzivassiliou","year":"2005","unstructured":"Hatzivassiliou G, Zhao F, Bauer DE, Andreadis C, Shaw AN, Dhanak D, et al. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell. 2005;8:311\u201321.","journal-title":"Cancer Cell"},{"key":"3910_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00109-019-01863-0","volume":"98","author":"AD Khwairakpam","year":"2020","unstructured":"Khwairakpam AD, Banik K, Girisa S, Shabnam B, Shakibaei M, Fan L, et al. The vital role of ATP citrate lyase in chronic diseases. J Mol Med. 2020;98:71\u201395.","journal-title":"J Mol Med"},{"key":"3910_CR15","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1080\/13543776.2022.2067478","volume":"32","author":"C Granchi","year":"2022","unstructured":"Granchi C. ATP-citrate lyase (ACLY) inhibitors as therapeutic agents: a patenting perspective. Expert Opin Ther Pat. 2022;32:731\u201342.","journal-title":"Expert Opin Ther Pat"},{"key":"3910_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57080-6","volume":"16","author":"AS Lee","year":"2025","unstructured":"Lee AS, Arefin TM, Gubanova A, Stephen DN, Liu Y, Lao Z, et al. Cerebellar output neurons can impair non-motor behaviors by altering development of extracerebellar connectivity. Nat Commun. 2025;16:1858.","journal-title":"Nat Commun"},{"key":"3910_CR17","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/nn761","volume":"4","author":"W Ye","year":"2001","unstructured":"Ye W, Bouchard M, Stone D, Liu X, Vella F, Lee J, et al. Distinct regulators control the expression of the mid-hindbrain organizer signal FGF8. Nat Neurosci. 2001;4:1175\u201381.","journal-title":"Nat Neurosci"},{"key":"3910_CR18","doi-asserted-by":"publisher","first-page":"4173","DOI":"10.1158\/0008-5472.CAN-18-3264","volume":"79","author":"G Peluffo","year":"2019","unstructured":"Peluffo G, Subedee A, Harper NW, Kingston N, Jovanovic B, Flores F, et al. EN1 is a transcriptional dependency in triple-negative breast cancer associated with brain metastasis. Cancer Res. 2019;79:4173\u201383.","journal-title":"Cancer Res"},{"key":"3910_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03230-7","volume":"24","author":"Y Cui","year":"2024","unstructured":"Cui Y, Zhang Y, Liu Y, Zhou Z, Zhu L, Zhou CX. EN1 promotes lung metastasis of salivary adenoid cystic carcinoma by regulating the PI3K-AKT pathway and epithelial-mesenchymal transition. Cancer Cell Int. 2024;24:51.","journal-title":"Cancer Cell Int"},{"key":"3910_CR20","doi-asserted-by":"crossref","unstructured":"Chang J, Guo C, Li J, Liang Z, Wang Y, Yu A, et al. EN1 regulates cell growth and proliferation in human glioma cells via Hedgehog signaling. Int J Mol Sci. 2022;23:1123.","DOI":"10.3390\/ijms23031123"},{"key":"3910_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202308537","volume":"11","author":"J Xu","year":"2024","unstructured":"Xu J, Roe JS, Lee E, Tonelli C, Ji KY, Younis OW, et al. Engrailed-1 promotes pancreatic cancer metastasis. Adv Sci. 2024;11:e2308537.","journal-title":"Adv Sci"},{"key":"3910_CR22","first-page":"2717","volume":"9","author":"M Zhang","year":"2016","unstructured":"Zhang M, Li H, Zou D, Gao J. Ruguo key genes and tumor driving factors identification of bladder cancer based on the RNA-seq profile. Onco Targets Ther. 2016;9:2717\u201323.","journal-title":"Onco Targets Ther"},{"key":"3910_CR23","doi-asserted-by":"publisher","first-page":"4767","DOI":"10.1038\/onc.2013.422","volume":"33","author":"AS Beltran","year":"2014","unstructured":"Beltran AS, Graves LM, Blancafort P. Novel role of Engrailed 1 as a prosurvival transcription factor in basal-like breast cancer and engineering of interference peptides block its oncogenic function. Oncogene. 2014;33:4767\u201377.","journal-title":"Oncogene"},{"key":"3910_CR24","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.it.2020.03.001","volume":"41","author":"D Priem","year":"2020","unstructured":"Priem D, van Loo G, Bertrand MJM. A20 and cell death-driven inflammation. Trends Immunol. 2020;41:421\u201335.","journal-title":"Trends Immunol"},{"key":"3910_CR25","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1002\/hep.29375","volume":"66","author":"S An","year":"2017","unstructured":"An S, Zhao LP, Shen LJ, Wang S, Zhang K, Qi Y, et al. USP18 protects against hepatic steatosis and insulin resistance through its deubiquitinating activity. Hepatology. 2017;66:1866\u201384.","journal-title":"Hepatology"},{"key":"3910_CR26","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1158\/1541-7786.MCR-20-0579","volume":"19","author":"X Liu","year":"2021","unstructured":"Liu X, Lu Y, Chen Z, Liu X, Hu W, Zheng L, et al. The ubiquitin-specific peptidase USP18 promotes lipolysis, fatty acid oxidation, and lung cancer growth. Mol Cancer Res. 2021;19:667\u201377.","journal-title":"Mol Cancer Res"},{"key":"3910_CR27","doi-asserted-by":"publisher","first-page":"25377","DOI":"10.1074\/jbc.M111.222760","volume":"286","author":"JE Duex","year":"2011","unstructured":"Duex JE, Comeau L, Sorkin A, Purow B, Kefas B. Usp18 regulates epidermal growth factor (EGF) receptor expression and cancer cell survival via microRNA-7. J Biol Chem. 2011;286:25377\u201386.","journal-title":"J Biol Chem"},{"key":"3910_CR28","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1002\/jmv.24819","volume":"89","author":"L Li","year":"2017","unstructured":"Li L, Lei QS, Kong LN, Zhang SJ, Qin B. Gene expression profile after knockdown of USP18 in Hepg2.2.15 cells. J Med Virol. 2017;89:1920\u201330.","journal-title":"J Med Virol"},{"key":"3910_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113560","volume":"42","author":"S Miyauchi","year":"2023","unstructured":"Miyauchi S, Arimoto KI, Liu M, Zhang Y, Zhang DE. Reprogramming of tumor-associated macrophages via NEDD4-mediated CSF1R degradation by targeting USP18. Cell Rep. 2023;42:113560.","journal-title":"Cell Rep"},{"key":"3910_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07772-0","volume":"16","author":"S Ye","year":"2025","unstructured":"Ye S, Chen J, Zheng Y, He M, Zhang Y, Cheng Y, et al. Targeting USP18 overcomes acquired resistance in hepatocellular carcinoma by regulating NCOA4 deISGylation and ferroptosis. Cell Death Dis. 2025;16:448.","journal-title":"Cell Death Dis"},{"key":"3910_CR31","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.18632\/aging.202359","volume":"13","author":"W Song","year":"2021","unstructured":"Song W, Yang K, Luo J, Gao Z, Gao Y. Dysregulation of USP18\/FTO\/PYCR1 signaling network promotes bladder cancer development and progression. Aging. 2021;13:3909\u201325.","journal-title":"Aging"},{"key":"3910_CR32","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/s41388-026-03733-9","volume":"45","author":"J Adams","year":"2026","unstructured":"Adams J, Suelzu CM, Strusi G, Stebbing J. Cancer-associated fibroblasts as key regulators of lipid metabolism in the tumour microenvironment. Oncogene. 2026;45:1211\u20139.","journal-title":"Oncogene"},{"key":"3910_CR33","doi-asserted-by":"crossref","unstructured":"Gyorfi AH, Matei AE, Fuchs M, Liang C, Rigau AR, Hong X, et al. Engrailed 1 coordinates cytoskeletal reorganization to induce myofibroblast differentiation. J Exp Med. 2021;218:e20201916.","DOI":"10.1084\/jem.20201916"},{"key":"3910_CR34","doi-asserted-by":"crossref","unstructured":"Jifu C, Lu L, Ding J, Lv M, Xia J, Wang J, et al. USP18 is associated with PD-L1 antitumor immunity and improved prognosis in colorectal cancer. Biomolecules. 2024;14:1191.","DOI":"10.3390\/biom14091191"},{"key":"3910_CR35","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/SAP.0000000000003045","volume":"88","author":"A Ural","year":"2022","unstructured":"Ural A, Bilgen F, Altintas Aykan D, Kocarslan S, Altintas Ural D, Seyithanoglu M, et al. The effect of udenafil on stasis zone in an experimental burn model. Ann Plast Surg. 2022;88:38\u201343.","journal-title":"Ann Plast Surg"},{"key":"3910_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.70013","volume":"16","author":"Q Wang","year":"2025","unstructured":"Wang Q, Ren S, Pan Z, Chen Y, Liu X. HOXA5 derives the malignant progression and cisplatin resistance of esophageal squamous cell carcinoma by regulating USP18-mediated IFI27 deubiquitination. Thorac Cancer. 2025;16:e70013.","journal-title":"Thorac Cancer"},{"key":"3910_CR37","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1158\/0008-5472.CAN-22-2405","volume":"83","author":"X Zhang","year":"2023","unstructured":"Zhang X, Cheng L, Gao C, Chen J, Liao S, Zheng Y, et al. Androgen signaling contributes to sex differences in cancer by inhibiting NF-kappaB activation in T cells and suppressing antitumor immunity. Cancer Res. 2023;83:906\u201321.","journal-title":"Cancer Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03910-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03910-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03910-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T22:03:12Z","timestamp":1788213792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03910-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":37,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2026,9,22]]}},"alternative-id":["3910"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03910-w","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study received approval from the Medical Ethics Committee of the Second Xiangya Hospital of Central South University (2024-Z0949-01), with informed consent provided by all enrolled patients. All procedures received approval from the Second Xiangya Hospital of Central South University (20250293) and complied with institutional standards.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}